Association between hepatitis C and hepatocellular carcinoma

Area of Science:

• Hepatology
• Oncology
• Virology

Background:

• Hepatocellular carcinoma (HCC) is a global health crisis, ranking as the fifth most common cancer and third leading cause of cancer death worldwide.
• Persistent hepatitis C virus (HCV) infection is a primary risk factor for HCC development, contributing significantly to its incidence and mortality.
• The rising incidence of HCC, projected to increase over the next two decades, is largely attributed to HCV infection and resulting cirrhosis.

Purpose of the Study:

• To review the intricate relationship between hepatitis C virus (HCV) infection and the development of hepatocellular carcinoma (HCC).
• To highlight the critical importance of early HCC detection for improved patient outcomes.
• To discuss the role of HCV in liver carcinogenesis and potential preventive strategies.

Main Methods:

• Literature review of epidemiological and clinical studies.
• Synthesis of current research on HCV's role in liver cancer.
• Analysis of the natural history and management complexities of HCC.

Main Results:

• Strong epidemiological evidence confirms HCV as a major risk factor for HCC.
• Early-stage HCC detection is vital for favorable clinical outcomes.
• Understanding the interplay between HCV and liver disease severity is essential for patient management.

Conclusions:

• HCV infection is a significant driver of liver carcinogenesis, leading to HCC.
• Effective management of HCV and its sequelae, like cirrhosis, is key to reducing HCC burden.
• Further research into preventive strategies and tailored treatment plans for HCV-related HCC is warranted.